Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda

AIDS Care - Psychological and Socio-Medical Aspects of AIDS/HIV

Volumn 22, Issue 3, 2010, Pages 271-278

  Kipp, Walter ^a   Alibhai, Arif ^a   Saunders, L Duncan ^a   Senthilselvan, Ambikaipakan ^a   Kaler, Amy ^a   Konde Lule, Joseph ^b   Okech Ojony, Joa ^c   Rubaale, Tom ^c  

^a UNIVERSITY OF ALBERTA   (Canada)

^b MAKERERE UNIVERSITY   (Uganda)

^c Kabarole Health Department   (Uganda)

Author keywords

Antiretroviral therapy; Gender; HIV AIDS; Uganda

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; RIFAMPICIN; STAVUDINE; VIRUS RNA;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; TREATMENT OUTCOME; UGANDA; VIRUS LOAD;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LOGISTIC MODELS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; RURAL HEALTH; RURAL HEALTH SERVICES; RURAL POPULATION; SEX FACTORS; SOCIOECONOMIC FACTORS; TREATMENT OUTCOME; UGANDA; VIRAL LOAD;

EID: 77951048471     PISSN: 09540121     EISSN: 13600451     Source Type: Journal    
DOI: 10.1080/09540120903193625     Document Type: Article

References (39)

1. Barth, R.E., van der Meer, J.T.M., Hoepelman, A.I.M., Schrooders, P.A., van de Vijver, D.A., Geelen, S.P.M., et al. (2008). Effectiveness of highly active antiretroviral therapy administered by general practitioners in rural South Africa. European Journal of Clinical Microbiology & Infectious Diseases, 27(10), 977-984.
2. Boulassel, M.R., Morales, R., Murphy, T., Lalonde, R.G., & Klein, M.B. (2006). Gender and long-term metabolic toxicities from antiretroviral therapy in HIV-1 infected persons. Journal of Medical Virology, 78(9), 1158-1163.
3. Braga, P., Cardoso, M.R.A., & Segurado, A.C. (2007). Gender differences in survival in an HIV/AIDS cohort from Sao Paulo, Brazil. AIDS Patient Care and STDs, 21(5), 321-328.
4. Braitstein, P., Boulle, A., Nash, D., Brinkhof, M.W.G., Dabis, F., Laurent, C., et al. (2008). Gender and the use of antiretroviral treatment in resource-constrained settings: Findings from a multicenter collaboration. Journal of Womens Health, 17(1), 47-55.
5. Braitstein, P., Brinkhof, M.W.G., Dabis, F., Schechter, M., Boulle, A., Miotti, P., et al. (2006). Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: Comparison between low-income and highincome countries. Lancet, 367(9513), 817-824.
6. Cressey, T.R., & Lallemant, M. (2007). Pharmacogenetics of antiretroviral drugs for the treatment of HIVinfected patients: An update. Infection Genetics and Evolution, 7(2), 333-342.
7. Floris-Moore, M., Lo, Y.T., Klein, R.S., Budner, N., Gourevitch, M.N., Moskaleva, G., et al. (2003). Gender and hospitalization patterns among HIVinfected drug users before and after the availability of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 34(3), 331-337.
8. Fogarty, L., Roter, D., Larson, S., Burke, J., Gillespie, J., & Levy, R. (2002). Patient adherence to HIV medication regimens: A review of published and abstract reports. Patient Education and Counseling, 46(2), 93-108.
9. Furler, M.D., Einarson, T.R., Walmsley, S., Millson, M., & Bendayan, R. (2006). Longitudinal trends in antiretroviral use in a cohort of men and women in Ontario, Canada. AIDS Patient Care and STDs, 20(4), 245-257.
10. Heath, K.V., Chan, K.J., Singer, J., O'Shaughnessy, M.V., Montaner, J.S.G., & Hogg, R.S. (2002). Incidence of morphological and lipid abnormalities: Gender and treatment differentials after initiation of first antiretroviral therapy. International Journal of Epidemiology, 31(5), 1016-1020.
11. Hirschhorn, L.R., McInnes, K., Landon, B.E., Wilson, I.B., Ding, L., Marsden, P.V., et al. (2006). Gender differences in quality of HIV care in Ryan White CARE Act-funded clinics. Womens Health Issues, 16(3), 104-112.
12. Holstad, M.K.M., Pace, J.C., De, A.K., & Ura, D.R. (2006). Factors associated with adherence to anti-retroviral therapy. Journal of the Association of Nurses in AIDS Care, 17(2), 4-15.
13. Kabarole District (2008). District information portal. Retrieved August 12, 2008, from http://www.kabarole. go.ug
14. Kaleebu, P., Pillay, D., Walker, A.S., Robertson, V., Gale, C.V., Enzama, R., et al. (2006). Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa. AIDS, 20(10), 1391-1399.
15. Kamya, M.R., Mayanja-Kizza, H., Kambugu, A., Bakeera-Kitaka, S., Semitala, F., Mwebaze-Songa, P., et al. (2007). Predictors of long-term viral failure among Ugandan children and adults treated with antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes, 46(2), 187-193.
16. Kang, S.Y., Goldstein, M.F., & Deren, S. (2008). Gender differences in health status and care among HIVinfected minority drug users. AIDS Care, 20(9), 1146-1151.
17. Kuyper, L.M., Wood, E., Montaner, J.S.G., Yip, B., O'Connell, J.M., & Hogg, R.S. (2004). Gender differences in HIV-1 RNA rebound attributed to incomplete antiretroviral adherence among HIV-infected patients in a population-based cohort. Journal of Acquired Immune Deficiency Syndromes, 37(4), 1470-1476.
18. Le Moing, V., Thiebaut, R., Chene, G., Sobel, A., Massip, P., Collin, F., et al. (2007). Long-term evolution of CD4 count in patients with a plasma HIV RNA persistentlyB500 copies/mL during treatment with antiretroviral drugs. HIV Medicine, 8(3), 156-163.
19. Manosuthi, W., Chaovavanich, A., Tansuphaswadikul, S., Prasithsirikul, W., Inthong, Y., Chottanapund, S., et al. (2007). Incidence and risk factors of major opportunistic infections after initiation of antiretroviral therapy among advanced HIV-infected patients in a resource-limited setting. Journal of Infection, 55(5), 464-469.
20. Marazzi, M.C., Liotta, G., Germano, P., Guidotti, G., Altan, A.D., Ceffa, S., et al. (2008). Excessive early mortality in the first year of treatment in HIV type 1-infected patients initiating antiretroviral therapy in resource-limited settings. AIDS Research and Human Retroviruses, 24(4), 555-560.
21. McNaghten, A.D., Hanson, D.L., Dworkin, M.S., Jones, J.L., & Adult Adolescent Spectrum, H.I.V.D. (2003). Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. Journal of Acquired Immune Deficiency Syndromes, 32(5), 499-505.
22. Miguez, M.J., Shor-Posner, G., Morales, G., Rodriguez, A., & Burbano, X. (2008). HIV treatment in drug users: Impact of alcohol use. Addiction Biology, 8(1), 33-37.
23. Muula, A.S., Ngulube, T.J., Siziya, S., Makupe, C.M., Umar, E., Prozesky, H.W., et al. (2007). Gender distribution of adult patients on highly active antiretroviral therapy (HAART) in Southern Africa: A systematic review. BMC Public Health, 7, 63.
24. Nicastri, E., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., Geraci, A., et al. (2005). Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS, 19(6), 577-583.
25. Nicastri, E., Leone, S., Angeletti, C., Palmisano, L., Sarmati, L., Chiesi, A., et al. (2007). Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. Journal of Antimicrobial Chemotherapy, 60(4), 724-732.
26. Perez, I.R., Bano, J.R., Ruz, M.A.L., Jimenez, A.D., Prados, M.C., Liano, J.P., et al. (2005). Health-related quality of life of patients with HIV: Impact of sociodemographic, clinical and psychosocial factors. Quality of Life Research, 14(5), 1301-1310.
27. Porter, K., Walker, S., Hill, T., Anderson, J., Leen, C., Johnson, M., et al. (2008). Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 cells/mm(3). Journal of Acquired Immune Deficiency Syndromes, 47(2), 202-205.
28. Reif, S., Whetten, K., & Thielman, N. (2007). Association of race and gender with use of antiretroviral therapy among HIV-infected individuals in the southeastern United States. Southern Medical Journal, 100(8), 775-781.
29. Samet, J.H., Horton, N.J., Traphagen, E.T., Lyon, S.M., & Freedberg, K.A. (2003). Alcohol consumption and HIV disease progression: Are they related? Alcoholism-Clinical and Experimental Research, 27(5), 862-867.
30. Smith, C.J., Sabin, C.A., Youle, M.S., Lampe, F.C., Bhagani, S., Madge, S., et al. (2007). Response to efavirenz-containing regimens in previously antiretroviral-naive HIV-positive patients the role of gender. Journal of Acquired Immune Deficiency Syndromes, 46(1), 62-67.
31. StataCorp (2007). Stata Statistical Software, Release 10. College Station, TX: StataCorp LP.
32. Tedaldi, E.M., Absalon, J., Thomas, A.J., Shlay, J.C., & van den Berg-Wolf, M. (2008). Ethnicity, race, and gender-differences in serious adverse events among participants in an antiretroviral initiation trial: Results of CPCRA 058 (FIRST study). Journal of Acquired Immune Deficiency Syndromes, 47(4), 441-448.
33. Uganda Ministry of Health (2003). National antiretroviral treatment and care guidelines for adults and for children (1st ed.). Kampala, Uganda: Author.
34. Uganda Ministry of Health (2006, July). Uganda HIV/ AIDS Sero-behavioral Survey 2004-2005. Kampala, Uganda: Author.
35. Umeh, O.C., & Currier, J.S. (2006). Sex differences in pharmacokinetics and toxicity of antiretroviral therapy. Expert Opinion on Drug Metabolism & Toxicology, 2(2), 273-283.
36. UNAIDS (2008). Towards universal access. Scaling up priority HIV/AIDS interventions in the health sector. Progress report 2008. Geneva, Switzerland: World Health Organization.
37. Weidle, P.J., Wamai, N., Solberg, P., Liechty, C., Sendagala, S., Were, W., et al. (2006). Adherence to antiretroviral therapy in a home-based AIDS care programme in rural Uganda. Lancet, 368(9547), 1587-1594.
38. Wester, C.W., Okezie, O.A., Thomas, A.M., Bussmann, H., Moyo, S., Muzenda, T., et al. (2007). Higher-thanexpected rates of lactic acidosis among highly active antiretroviral therapy-treated women in Botswanapreliminary results from a large randomized clinical trial. Journal of Acquired Immune Deficiency Syndromes, 46(3), 318-322.
39. Wolbers, M., Battegay, M., Hirschel, B., Furrer, H., Cavassini, M., Hasse, B., et al. (2007). CD4(-) T-cell count increase in HIV-1-infected patients with suppressed viral load within 1 year after start of antiretroviral therapy. Antiviral Therapy, 12(6), 889-897.